Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-023730
Filing Date
2013-04-29
Accepted
2013-04-29 13:49:34
Documents
1
Period of Report
2013-04-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd377631.html 4  
1 FORM 4 rrd377631.xml 4 10368
  Complete submission text file 0001181431-13-023730.txt   11701
Mailing Address SOLAZYME, INC. 225 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address
MILLER DANIEL H (Reporting) CIK: 0000902448 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35189 | Film No.: 13790641

Mailing Address 225 GATEWAY BLVD. S. SAN FRANCISCO CA 94080
Business Address 225 GATEWAY BLVD. S. SAN FRANCISCO CA 94080 650-780-4777
SOLAZYME INC (Issuer) CIK: 0001311230 (see all company filings)

EIN.: 331077078 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2860 Industrial Organic Chemicals